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Background: The purpose of this study was to describe targeting accuracy in functional neurosurgery using
incisionless transcranial magnetic resonance (MR)-guided focused ultrasound technology.
Methods: MR examinations were performed before and 2 days after the ultrasound functional neurosurgical
treatment to visualize the targets on T2-weighted images and determine their coordinates. Thirty consecutive
targets were reconstructed: 18 were in the central lateral nucleus of the medial thalamus (central lateral
thalamotomies against neurogenic pain), 1 in the centrum medianum thalamic nucleus (centrum medianum
thalamotomy against essential tremor), 10 on the pallido-thalamic tract (pallido-thalamic tractotomies against
Parkinson's disease), and 1 on the cerebello-thalamic tract (cerebello-thalamic tractotomy against essential tremor).
We describe a method for reconstruction of the lesion coordinates on post-treatment MR images, which were
compared with the desired atlas target coordinates. We also calculated the accuracy of the intra-operative target
placement, thus allowing to determine the global, planning, and device accuracies. We also estimated the target
lesion volume.
Results: We found mean absolute global targeting accuracies of 0.44 mm for the medio-lateral dimension
(standard deviation 0.35 mm), 0.38 mm for the antero-posterior dimension (standard deviation 0.33 mm), and
0.66 mm for the dorso-ventral dimension (standard deviation 0.37 mm). Out of the 90 measured coordinates, 83
(92.2%) were inside the millimeter domain. The mean three-dimensional (3D) global accuracy was 0.99 mm
(standard deviation 0.39 mm). The mean target volumes, reconstructed from surface measurements on 3D T1
series, were 68.5 mm3 (standard deviation 39.7 mm3), and 68.9 mm3 (standard deviation 40 mm3) using an
ellipsoidal approximation.
Conclusion: This study demonstrates a high accuracy of the MR-guided focused ultrasound technique. This high
accuracy is due not only to the device qualities but also to the possibility for the operator to perform on-going
real-time monitoring of the lesioning process. A precise method for determination of targeting accuracy is an
essential component and basic requirement of the functional neurosurgical activity, allowing an on-going control
of the performed therapeutic work indispensable for any target efficiency analysis and the maintenance of a low
risk profile.
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The therapeutic application of any technology to func-
tional neurosurgery requires refined target reconstructions
and precise targeting accuracy measurements, which
should be within the millimeter domain. As targets are
in normal tissue, coordinates have to be established for
each target on the basis of a stereotactic atlas of the
human brain. Such an atlas uses internal landmarks to
position a coordinate system onto the brain, allowing
the placement of any desired target inside the brain.
We use the Morel Stereotactic Atlas of the Human
Thalamus and Basal Ganglia [1,2], which provides,
better than other currently used atlases, the following
essential qualities: (1) a special guillotine has been used
to guarantee proper cutting angles, (2) stereotactic maps
were drawn every 0.9 mm, (3) several histological stain-
ing techniques were used (multiarchitectonic atlas), and
(4) the atlas is based on a histological experience fromFigure 1 MR prescription of the T2 FRFSE orthogonal sagittal and axi
taking care of the tilting (A) and rotation (B) corrections for the planning o
the center of the third ventricle. Axial series is prescribed using three-plane
central prescription line on the mid-sagittal slice passes exactly through the
on coronal slice (C).seven human autopsy brains, and the consecutive atlas
maps were drawn from four hemispheres.
In functional neurosurgery, two steps of the treatment
procedure need to be performed with precision inside
the millimeter domain: (1) the projection, based on the
atlas, of the three coordinates of a chosen target onto
the intra-operative magnetic resonance (MR) imaging
and (2) the application of heat in the chosen target. The
determination of the three-dimensional position of this
target on intra-operative images and of the therapeutic
lesion on post-operative MR imaging allows then to
establish the targeting accuracy of the whole thera-
peutic procedure.
The targeting accuracy measurement procedure presented
here can be used in any functional neurosurgical setup.
It has been developed in the context of a clinical study
which has a goal to provide relief to patients suffering
from chronic therapy-resistant functional brain disordersal series. Sagittal series is prescribed on three-plane localizer images,
f the mid-sagittal slice (D): the central prescription lines pass through
localizer coronal (C) and the T2 FRFSE mid-sagittal (D) scans. The
center of the two commissures (red circles on D) and tilt is corrected
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by performing small therapeutic ablations in the thal-
amus and subthalamus using the ExAblate Neuro sys-
tem (InSightec Ltd, Tirat Carmel, Israel). This device
allows the incisionless transcranial MR-guided applica-
tion of focused ultrasound energy (MRgFUS) into brain
tissue. A first paper only on neurogenic pain patients [3]
analyzed the targeting accuracy of this technique for 18
targets, and another paper [4] described our targeting
experience and reconstruction method on the first 11
targets of the current project. In the following, we present
our targeting accuracy measurements for the now avail-
able consecutive 30 focused ultrasound targets.Methods
The presented data are part of a study approved by
the Ethics Committee of Kanton Aargau/Solothurn and
Swissmedic (Study No. 2010/041).Atlas coordinate system
The neuroanatomical landmarks used in the Morel atlas
[1,2] are the anterior commissure (ac) and the posterior
commissure (pc). On a mid-sagittal scan (Figure 1D), a
line passing through the center of these commissures
(inter-commissural line, ICL) is used to determine the
axial dorso-ventral (DV) ‘0’ plane. On an axial scan
(Figure 2, left), the ICL is drawn passing through the
middle of the third ventricle. The medio-lateral (ML)
axes (right and left) are parallel to the ac and pc lines,
themselves perpendicular to the ICL. On the atlas maps,
the reference grid starts laterally in ‘0’ position in the
middle of the ventricle. However, the width of the ven-
tricle can vary significantly from patient to patient; the
thalamo-ventricular border has thus been chosen as theFigure 2 Reconstruction of the realized target. Realized target reconstru
T2 FRFSE axial images. The reconstruction of the ac and pc lines and of the
parallel to the MCL, while the AP direction is measured perpendicularly to
coordinates of the displayed realized target are 2 mm ventral to the ICL, 6.
to the MCL.reference point for the determination of the ML target
coordinate (Figure 2, right).Targets and accuracies
There are three different kinds of targets, defined by the
three-dimensional coordinates of their center, for each
accuracy measurement: the chosen target, based on
surgical experience and established in terms of atlas
coordinates, has been called the atlas target. Following
the atlas-based manual determination of the position
of the target on the intra-operative MR images, its MR
coordinates (in the right-anterior-superior (RAS) domain)
are entered in the ExAblate software. These MR coor-
dinates define the prescribed target. Finally, the pos-
ition of the center of the therapeutic thermolesion,
defined as the realized target, is measured on the MR
post-operative exam.
On this basis, three accuracies can be computed: (1)
the global accuracy, which is defined as the difference
between the realized and the atlas target center coordi-
nates, (2) the device accuracy, defined by the difference
between the prescribed and the realized target center co-
ordinates, and (3) the planning accuracy, defined by the
difference between the atlas and the prescribed target
center coordinates. It is to be noted that the device
accuracy contains in fact (1) a purely technical accuracy,
which depends on the construction of the machine and
(2) a manual correction of the electronic steering (with
its own accuracy) which can be applied by the operator
during the treatment if the aiming of the machine is not
on spot. Thus, the device accuracy may be considered as
machine- as well as man-based. However, this man-based
manual correction depends on the quality of the MR ther-
mal maps and is therefore technically related.ction (AP and ML coordinates of the center) on 2 days post-operative
MCL is done on the DV0 plane (left). The ML coordinate is measured
this line on the V2 plane (right) where the target is most visible. The
77 mm lateral to the thalamo-ventricular border, and 0.23 mm anterior
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analyzed are the global, the device and the planning
accuracies, which are linked as follows:
Global accuracy ¼ Device accuracy
þ Planning accuracy
Each of these three accuracies is a three-dimensional
signed vector and is calculated in the three dimensions:
ML, antero-posterior (AP), and DV. The Euclidean length
of the global accuracy vector is called the 3D global
accuracy.
When computing the mean over a group of patients,
the ML, AP, and DV coordinates of their global accur-
acies should not compensate each other. For example,
if a +1-mm difference on a direction is measured for
one targeting and a −1-mm difference for another
targeting in the same direction, the mean will be 0. The
mean should however be 1 mm, and this is obtained by
using the absolute value of the global accuracies of
all patients.
Tools
A brief description of the tools used to determine and
reconstruct targets is shown on Table 1. The intra-
operative target determination is done on the MR work-
station, the post-operative prescribed target determination
on the ExAblate workstation, and postoperative target
reconstructions on a usual desktop computer (not men-
tioned in the table).
Imaging
The post-operative MR imaging was performed 2 days
after the MRgFUS treatment. We have chosen this
moment based on our year-long experience with radio-
frequency (RF) lesioning and on our earlier observations
[3] with MRgFUS, indicating that the visualization of the
therapeutic lesion on MR pictures is optimal (i.e., full-
blown) at this time after the thermocoagulation. The
histological process of thermocoagulation is reprodu-
cible but shows nevertheless some variation along time,Table 1 Tools for targeting accuracy measurement
Tool
Hardware InSightec ExAblate 4000 Neuro
GE Discovery MR750 3.0 T Body coil
32-channel head coil
Software InSightec ExAblate FUS Brain software
GE viewer software (on MR console)
Carestream PACS V11.0 (DICOM viewer)
Synedra View Personal 3 (DICOM viewer)
The Mathworks Matlab R2009b
Tools used for target determination (intra-operative) and target reconstructions (poso that we cannot exclude a certain amount of in-
homogeneity of lesion development at the chosen point
in time.
The precision of all target determinations and recon-
structions rely on MR imaging. If the three orientations
are not orthogonal and precisely prescribed, a very sig-
nificant error in target determination and measurements
may happen. All MR series are cut in the same way as
the Morel atlas [1,2] maps: the ‘zero’ axial plane passes
through the centers of the ac and pc (Figure 1D). A
minimum of two out of the three orientations (axial,
sagittal, and coronal) is required in order to prescribe
a target or to perform a target reconstruction. In the
following, only the sagittal and the axial series have
been used.
The sagittal scans are prescribed on the ‘three-plane
localizer’ images, using axial and coronal orientations
(Figure 1A,B). Care must be taken to prescribe a precisely
mid-sagittal slice, thus allowing the detailed visualization
of the ac and pc. This is performed mainly on a
transthalamic three-plane localizer axial image: the
prescription of the mid-sagittal slice must pass in the
middle of the third ventricle with the proper angle
(Figure 1B). The tilt of this plane has to be checked on
the coronal three-plane localizer image (Figure 1A),
adjusting also here the angle to be strictly mid-sagittal.
The prescription of the axial series is then done using
this mid-sagittal image and the same coronal three-
plane localizer image. The central axial slice has to
pass through the centers of the ac and pc (Figure 1D),
while its tilt has to follow the patient's head tilt as seen
on the coronal images (Figure 1C).
Intra-operative atlas target determination
The atlas target coordinates are projected onto intra-
operative transthalamic MR T2 fast relaxation fast spin
echo (FRFSE) sagittal and axial series, with 2-mm thick-
ness and a 0-mm gap between slices.
Using the GE viewer software, the DV0 plane (slice
containing the two commissures) is located on the axial




Operation and post-operative prescribed target center measurement
Intra-operative target determination




Figure 3 Three-dimensional ellipsoid and its volume
calculation. Top: three-dimensional ellipsoid with its half-axes a, b,
and c. Bottom: equation of the volume of a
three-dimensional ellipsoid.
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the ac and pc lines are drawn perpendicularly to the ICL
and passing through the center of each commissure.
The mid-commissural line (MCL) is drawn on this
plane, at equal distance from the ac and pc lines
(Figure 2, left). The AP target coordinate is positioned
in relation to the one of the three landmarks - ac, pc, or
mid-commissural point - which is closest to the target,
with the goal to reduce the effect of the inter-individual
variability (Figure 2, right). These lines are then copied
on all the slices of the axial series.
The next step is to browse the axial series in order to
find the right DV plane which depends on the DV co-
ordinate of the atlas target. The AP position of the target
is determined by drawing a line passing through the
given AP coordinate, a line which is parallel to the ac,
pc, and MCL. This line is then used to determine the
ML position of the target, which is given starting from
the thalamo-ventricular border. The target is now fully
determined; the last point is to write down the RAS co-
ordinates of the target in order to enter them into the
ExAblate software.
Realized target reconstruction
The position of the center of the lesion, or realized tar-
get, is determined on post-operative MR T2 FRFSE sa-
gittal and axial series in essentially the same manner as
for the intra-operative target determination. The post-
operative MR series are the same as the ones used for
the intra-operative target determination, except that a
32-channel head coil is now used instead of the MR
body coil.
As explained above, the ICL and then the ac, pc, and
MCL are drawn and copied on all the slices of the axial
series. Then, the axial slice where the lesion is the most
visible is located and the center of the lesion determined.
On this particular slice, measuring the distance, parallel
to the ac line, pc line, or MCL, from the center of the
lesion to the thalamo-ventricular border gives the ML
coordinate of the realized target. Measuring the dis-
tance between this center and the ac line, pc line, or
MCL perpendicularly to them gives its AP coordinate.
The exact DV coordinate of the realized target is then
determined using the sagittal series. On the mid-sagittal
slice, the ICL is drawn and copied on all slices of the
series. The slice where the lesion is most visible is lo-
cated and the center of the lesion determined. The
distance between this center and the ICL, perpendicu-
larly to it, gives then the DV coordinate of the realized
target.
Prescribed target reconstruction
To check the accuracy of the placement of the target into
the ExAblate software (RAS coordinates of the prescribedtarget), the ‘Replay Mode’ of the ExAblate workstation is
used. The process is nearly the same as for the reconstruc-
tion of the center of the realized target; the only difference
is that the blue rectangle representing the prescribed tar-
get has to be located instead of the lesion. The second, less
important difference is that the Replay Mode of the
ExAblate software is used instead of the GE viewer soft-
ware on the MR console.
Estimated lesion volume
The volume of the lesion could be estimated by measur-
ing its diameter and height and computing the volume
as if the lesion was a cylinder. The technique used is
more accurate, as it compares the shape of the lesion to
a three-dimensional ellipsoid (Figure 3). The first two
half-axes (‘a’ and ‘b’ on Figure 3) are obtained by meas-
uring the lesion diameters (and taking the half of it) on
the axial scan where the lesion is the most visible. The
Moser et al. Journal of Therapeutic Ultrasound 2013, 1:3 Page 6 of 10
http://www.jtultrasound.com/content/1/1/3last half-axis (‘c’ on Figure 3) is obtained by measuring
the height of the lesion (and also taking the half of it) on
a sagittal scan where it is the largest. In order to check
the accuracy of the ellipsoidal approximation, the lesion
volume has also been reconstructed from axial 3D T1
series using surface measurements of the lesion from all
slices where it is visible.
Results
For the 30 examined targets, we determined first the
absolute global accuracy for each direction (Figure 4).Figure 4 Global targeting accuracy. Absolute value of the global accura
mean and standard deviation (Std Dev) for each. ML stands for medio-laterThe mean was 0.44 mm for the ML dimension (stand-
ard deviation 0.35 mm), 0.38 mm for the AP dimension
(standard deviation 0.33 mm), and 0.66 mm for the DV
dimension (standard deviation 0.37 mm). Over 90 mea-
sured coordinates, 7 (7.8%) exceeded the millimeter
domain (maximum 1.6 mm). Figure 5 displays the plan-
ning and device accuracies of the 30 targets. The mean
three-dimensional global accuracy (Figure 6) was 0.99 mm
(standard deviation 0.39 mm).
Reconstructing the lesion volume from an axial 3D
T1-weighted series, we obtained a mean lesion volumecies of the 30 reconstructed targets in the three directions, with the
al, AP for antero-posterior, and DV for dorso-ventral.
Figure 5 Device and planning accuracies. Device and planning accuracies for the 30 reconstructed targets. The sum of the absolute values of
these two accuracies gives the global one. ML stands for medio-lateral, AP for antero-posterior, and DV for dorso-ventral.
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39.7 mm3, see Figure 7A). Using the ellipsoid approxi-
mation, the mean volume of the first 27 lesions was
68.9 mm3 (standard deviation 40 mm3, see Figure 7B).
The plot of the differences between the two techniques
is shown in Figure 7C. The last three lesions have been
dismissed from Figure 7 because they are larger due to
target heating repetition (see the ‘Discussion’ section).There were no device- or procedure-related complica-
tions and no post-treatment neurological deficits.
Discussion
Along the last 23 years, our group has developed and
applied as a routine target accuracy controls based
on the Morel atlas [1,2]. This was warranted by our
choice to perform selective small ablations based on
Figure 6 Three-dimensional global targeting accuracy. Absolute value of the global accuracies of the 30 reconstructed targets in a
three-dimensional space, with the mean and standard deviation (Std Dev).
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[2,5-21].
We would like to stress here the importance of two
factors contributing to adequate target determination
and targeting accuracy measurement: first the proper
alignment of the used MR slice stacks with correction of
tilts and rotations, particularly relevant for lateral tar-
gets, and second the necessity of a high-resolution
visualization of the two commissures, allowing a refined
determination of their centers under high magnification.
In our experience, the described T2-weighted imaging
without 3D reformatting has been the best option, for
post-operative imaging using a 32-channel head coil,
but also for intra-operative imaging using the body coil
of the GE Discovery MR750 system.
We have demonstrated here, using the described
method for 30 targets, that 92.2% of our target coordi-
nates lie within the millimeter domain, with a mean
absolute global targeting accuracy of the focused ultra-
sound treatment between 0.38 and 0.66 mm and a
mean 3D global accuracy of 0.99 mm. The MR-guided
focused ultrasound technique fulfills thus the basic
criterion of a mean accuracy smaller than 1 mm for
the three coordinates, confirming two earlier studies
[3,4] on 18 and 11 targets, respectively. It compares
indeed favorably with accuracy studies of the deep
brain stimulation (DBS) and RF techniques. In DBS,
Bjartmarz and Rehncrona [22] found an error 3D vec-
tor of 2.5 mm (as compared to our value of 0.99 mm),
and Hamid et al. [23] published errors of 0.48, 0.69,and 2.9 mm for the three axes (as compared to our
values of 0.44, 0.38, and 0.66 mm). RF lesioning accuracy
values were 0.8, 0.9, and 1.9 mm for the three axes in the
study of Bourgeois et al [24]. These authors proposed that
their DV accuracy of 1.9 mm is due to the mechanical shift
of brain tissue, an interpretation fitting with the smaller
value found in this study (0.66 mm), thanks to the absence
of mechanical brain penetration. As for gamma knife,
Massager et al. [25] published a 3-D vector value of
0.91 mm, close to our value of 0.99 mm.
The analysis of the lesion volumes applying an ellips-
oidal approximation on T2-weighted imaging came out
to be very close to lesion volume reconstructions from
T1-weighted imaging (Figure 7). The ellipsoidal approxi-
mation may thus be proposed as a simple yet accurate
estimation of the lesion volume. The three last measure-
ments showed larger volumes because a repetition of
the end temperature came out to be warranted to ob-
tain a complete lesioning in fiber tracts, a measure which
is not necessary in a nuclear (thalamic) area (Magara A.
et al., unpublished work). These last three measurements
have therefore been dismissed from the lesion volume
analysis.
A precise method for determination of targeting accur-
acy is an essential component and basic requirement of
the functional neurosurgical activity, allowing an on-
going control of the performed therapeutic work indis-
pensable for any target efficiency analysis and for the
maintenance of a low risk profile. The applied target
reconstruction procedure entails of course a certain
Figure 7 Lesion volumes. Volumes of the first 27 lesions with mean and standard deviation (Std Dev) using two different methods. (A) Volumes
reconstructed from surface measurements on 3D T1-weighted post-operative scans. (B) Calculated volumes with the three-dimensional ellipsoid
approximation. (C) Differences between the ellipsoidal approximations and the reconstructed volumes in percent.
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basis of our experience to be each around half a millimeter.
These errors are mainly variations of thalamo-ventricular
border position due to differences of MR picture
windowing, thickness of the MR slices (2 mm), and
determination of the centers of the ac and pc and of
the center of more or less regular ellipsoidal lesions.
Most of these errors are related to the fact that the
performed steps are based on individual visual and
manual estimation. One limitation of our study is that
we have not made an inter-individual estimation of
measurement variations, another is that we have not
used the coronal MR planes to countercheck our mea-
surements on sagittal and axial series. In addition, variable
amounts of perilesional edema may have influenced some
measurements, particularly of the ML lesion coordinate.
The accuracy obtained with the MRgFUS system obeys
clinical efficiency and safety criteria and is related to
the device qualities but also to the possibility for the
operator to manually correct the targeting in thecontext of an on-going real-time monitoring of the
lesioning process. Future technological developments
in the MRgFUS domain can be expected to contribute to
further progresses in targeting precision, together with
increased operator experience, considering the particu-
lar importance of human decision-making for an opti-
mized treatment process.Competing interests
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